DRIVE Meeting 2027 Agenda

The Biology of DRIVE

Connecting ancestral biology, representative clinical research, patient outcomes, and practical strategies for improving DRIVE scores.
Friday, March 12th, 2027

Meeting Chair: Ruemu E. Birhiray

Time Session Title
6:30 AM - 7:00 AM Continental Breakfast
7:00 AM - 7:10 AM The Biology of DRIVE: Connecting Discovery, Representation, and Better Care
Ruemu E. Birhiray, MD
7:20 AM - 7:40 AM Beyond the Average Patient: Ancestral Genomic Variation and Its Implications for Hematologic Cancer Care
Andrew Hantel, MD, MPH
7:40 AM - 8:00 AM The Signals of Senescence: SASP, Ancestry, and the Cancer Microenvironment
Sanket Shah, PhD
8:00 AM - 8:20 AM Duffy-Null, Different Decisions: Interpreting Blood Counts and Outcomes in Multiple Myeloma
Lauren E. Merz, MD
8:20 AM - 8:35 AM From Biological Variation to Clinical Action: Questions and Panel Discussion
8:35 AM - 8:55 AM Whose Evidence Gets Heard? Ancestry Representation in Publications and Scientific Presentations
Catherine Lai, MD, MPH
8:55 AM - 9:15 AM Artificial Intelligence at the Intersection: Using Ancestry and AI to Build More Representative Clinical Trials
Seungtaek Lee
9:15 AM - 9:30 AM Raising the Score, Strengthening the Evidence: Questions and Panel Discussion
9:30 AM - 9:40 AM Coffee Break
9:40 AM - 10:00 AM When DRIVE Fails: Duty of Care, Patient Harm, and Legal Accountability
Dayna Bowen Matthew, JD, PhD, or Michelle Mello, JD, PhD²
10:00 AM - 10:20 AM The Cost of Being Unrepresented: What Patients Lose When Evidence Leaves Them Out
Joan Reede, MD, or Merlin Chowkwanyun, PhD, MPH
10:20 AM - 10:40 AM Who Delivers the Care Matters: Representation, Cultural Alignment, and Trust in the Healthcare Team
Lisa Cooper, MD, MPH
10:40 AM - 10:55 AM When Evidence and Care Fall Short: Questions and Panel Discussion
10:55 AM - 11:05 AM Coffee Break
11:05 AM - 11:35 AM Keynote Conversation: The Next Chapter in DRIVE — From Commitment to Measurable Change
Robert Winn, MD
11:35 AM - 11:50 AM Evidence That Serves Every Patient: A Public Policy Approach to Cancer Treatment Decisions
Renuka Iyer, MD
11:50 AM - 12:05 PM Opening the Trial Door: Less Red Tape, Greater Access, and a Global Coalition for Representative Clinical Trials
Ishwaria Subbiah, MD, MS, FASCO
12:05 PM - 12:20 PM Setting the Standard: National Organizations, Data Reporting, and Abstract Selection
Belinda Avalos, MD
12:20 PM - 12:35 PM Measuring What Matters: Biostatistical Advances and the Next DRIVE Calculator
Todd Burus, PhD, MAS
12:35 PM - 12:55 PM Tomorrow's Steps, Today's Commitments: Questions and Closing Panel Discussion
12:55 PM - 1:00 PM Closing Remarks
Ruemu E. Birhiray, MD
1:00 PM Luncheon